Retatrutide, by Soma Pharmaceuticals , is attracting significant attention as a novel method for obesity regulation. This unique compound integrates the activity of a GLP-1 receptor stimulant and a GIP receptor stimulant, aiming to not only promote weight loss but also address associated metabolic factors. Early patient data have demonstrated encou